REMİFENTANİLİN ELEKTROKONVULSİF TEDAVİDE NÖBET SÜRESİNE VE AKUT HEMODİNAMİK YANITA OLAN ETKİLERİ

Amaç: Elektrokonvulsif tedavi EKT çeşitli psikiyatrik hastalıkların tedavisinde kullanılan bir tedavi yöntemidir. EKT esnasında elektrik uyarısını takiben akut hiperdinamik bir yanıt oluşur.Çalışmamızda remifentanilin oluşan nöbet esnasında görülen geçici hiperdinamik yanıtın kontrolünde kullanılabileceğini öngörmekteyiz. Metod: 20 erkek ve 20 kadın hasta randomize şekilde çalışmaya dahil edilmiştir. Toplamda 7 EKT tedavisi alan hastaların sondan bir önceki EKT uygulamasında anestezi indüksyonu propofol 1mg/kg ile yapılırken grup1 son EKT uygulaması nda propofol 0.5 mg/kg ve remifentanil 1μg/kg kullanılmıştır grup 2 . Bulgular: Grup 1' de kan basıncı değerleri belirli şekilde yüksek iken grup 2' de daha stabil seyretmiştir p
Anahtar Kelimeler:

EKT, remifentanil, nöbet süresi

EFFECT OF REMIFENTANIL ON SEIZURE DURATION AND ACUTE HEMODYNAMIC RESPONSES DURING ELECTROCONVULSIVE THERAPY

Aim: Electroconvulsive therapy ECT is used asa treatment option for individuals with several psychiatric disorder. ECT is often associated with acute hyperdynamic responses immediately after the electrical stimulus. We hypohesized that remifentanil would attenuate the transient hyperdynamic response to ECT without interfering with the seizure activity Methods: 20 men and 20 women,total 40 patients who went on ECT enrolled in this prospective, randomized trial, each receiving a total of seven electroconvulsive therapies.The patients with cardiac disseases, nouromuscular disseases, instabil hypertension, uncontroled metabolic diseases were excluded. In group I anesthesia induction was achived with propofol 1mg/kg for next to last ECT and in group II we used propofol 0.5 mg/kg and remifentanil 1μg/kg for the last ECT Results: Blood presure measurments significantly were higer in group I after ECT session while it was more stable in group II p

___

  • Sienaert P. What we have learned about electroconvulsive therapy and its relevance for the practising psychiatrist. Can J Psychi- atry 2011;56(1):5-12.
  • Bolwig TG. How does electroconvulsive the- rapy work? Theories on its mechanism. Can J Psychiatry 2011;56(1):13-18.
  • Folk JW, Kellner CH, Beale MD, Conroy JM, Duc TA. Anesthesia for electroconvulsive the- rapy: a review. J ECT 2000;16(2):157-170.
  • Ding Z, White PF. Anesthesia for ele- ctroconvulsive therapy. Anesth Analg 2002;94(5):1351-1364.
  • Wajima Z, Yoshikawa T, Ogura A, et al. The effects of diltiazem on hemodynamics and seizure duration during electroconvulsive therapy. Anesth Analg 2001;92(5):1327- 1330.
  • McCall WV. Asystole in electroconvulsive therapy: Report of four cases. J Clin Psychi- atry. 1996;57(5):199-203.
  • Fu W, Stool LA, White PF, Husain MM. Acute hemodynamic responses to electroconvulsi- ve therapy are not related to the duration of seizure activity. J ClinAnesth 1997;9(8):653- 657.
  • Van den Broek WW, Groenland TH, Mulder PG, et al. [Beta-blockers and electroconvul- sive therapy: a review]. Tijdschr Psychiatr 2008;50(4):205-215.
  • Chen ST. Remifentanil: a review of its use in electroconvulsive therapy. J ECT. 2011 27(4):323-7.
  • Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propo- fol, and etomidate for electroconvulsive the- rapy. Anesth Analg 1995;81(3):596-602.
  • Daniel WF. ECT seizure duration and al- leviation of depression. Br J Psychiatry 1983;143:523.
  • Sackeim HA. The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J ECT 1999;15(1):5-26.
  • Daniel WF. ECT seizure duration and effica- cy. Br J Psychiatry 1995;166(3):399-401.
  • Andersen FA, Arsland D, Holst-Larsen H. Ef- fects of combined methohexitone-remifen- tanilanaesthesia in electroconvulsive therapy. Acta Anaesthesiol Scand 2001;45(7):830-3.
  • Lalla FR, Milroy T. The current status of seizure duration in the practice of electro- convulsive therapy. Can J Psychiatry 1996 ;41(5):299-304.
  • Fear CF, Littlejohns CS, Rouse E, McQuail P. Propofolanaesthesia in electroconvulsive therapy. Reduced seizure duration may not be relevant. Br J Psychiatry 1994;165(4):506- 9.
  • Rampton AJ, Griffin RM, Stuart CS, Durcan JJ, Huddy NC, Abbott MA. Comparison of methohexital and propofol for electrocon- vulsive therapy: effects on hemodynamic responses and seizure duration. Anesthesio- logy 1989;70(3):412-417.
  • Swartz CM. Propofol Anesthesia in ECT. Convuls Ther 1992;8(4):262-266.
  • Porter R, Booth D, Gray H, Frampton C. Ef- fects of the addition of remifentanil to pro- pofol anesthesia on seizure length and pos- tictal suppression index in electroconvulsive therapy. J ECT 2008;24(3):203-207.
  • Gaines GY 3rd, Rees DI. Anesthetic conside- rations for electroconvulsive therapy. South Med J 1992;85(5):469-482.
  • Vishne T, Aronov S, Amiaz R, EtchinA, Grun- haus L. Remifentanil supplementation of propofol during electroconvulsive therapy: effect on seizure duration and cardiovascular stability. J ECT 2005;21(4):235-238.
  • Sebel PS, Hoke JF, Westmoreland C, Hug CC Jr, Muir KT, Szlam F. Histamine concentrati- ons and hemodynamic responses after remi- fentanil. Anesth Analg 1995;80(5):990-993.
  • Recart A, Rawal S, White PF, Byerly S, Thor- nton L. The effect of remifentanil on seizure duration and acute hemodynamic responses to electroconvulsive therapy. Anesth Analg 2003;96(4):1047-1050.
  • Haas S, Nash K, Lippmann SB. ECT-induced seizure durations. J Ky Med As soc 1996;94(6):233-236.